Guardion Health Sciences Inc Quick Ratio (GHSI) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Guardion Health Sciences Inc   (NASDAQ: GHSI)

Guardion Health Sciences Inc 's Quick Ratio

GHSI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Guardion Health Sciences Inc 's Cash & cash equivalent grew by 164.46 % in the Q2 2024 sequentially, while Current Liabilities decreased, this led to improvement in Guardion Health Sciences Inc 's Quick Ratio to 16.16, above Guardion Health Sciences Inc average Quick Ratio.

Within Major Pharmaceutical Preparations industry 55 other companies have achieved higher Quick Ratio than Guardion Health Sciences Inc in second quarter 2024. While Quick Ratio total ranking has improved so far during the Q2 2024 to 188, from total ranking in the first quarter 2024 at 420.

Explain Quick Ratio?
How much Cash & cash equivalents GHSI´s has?
What are GHSI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GHSI Quick Ratio (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2
Y / Y Current Liabilities Change -54.05 % -41.64 % -81.87 % -16.94 % 18.97 %
Y / Y Cash & cash equivalent Change 77.18 % -36.12 % -40.32 % -40.85 % -41.21 %
Quick Ratio MRQ 16.16 4.41 8.74 5.35 4.19
GHSI's Total Ranking # 188 # 420 # 397 # 538 # 780
Seq. Current Liabilities Change -27.83 % 74.74 % -49.19 % -28.29 % -8.33 %
Seq. Cash & cash equivalent Change 164.46 % -11.87 % -16.95 % -8.47 % -4.66 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 56
Healthcare Sector # 87
Overall Market # 188


Quick Ratio Statistics
High Average Low
44.09 8.01 0.11
(Mar 31 2021)   (Mar 31 2019)




Financial Statements
Guardion Health Sciences Inc 's Current Liabilities $ 1 Millions Visit GHSI's Balance sheet
Guardion Health Sciences Inc 's Cash & cash equivalent $ 15 Millions Visit GHSI's Balance sheet
Source of GHSI's Sales Visit GHSI's Sales by Geography


Cumulative Guardion Health Sciences Inc 's Quick Ratio

GHSI's Quick Ratio for the trailling 12 Months

GHSI Quick Ratio

 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth -56.13 % -43.42 % -31.3 % 51.06 % 57.32 %
Y / Y Cash & cash equivalent TTM Growth -15.46 % -39.95 % -43 % -33.23 % -19.66 %
Quick Ratio TTM 7.92 5.16 4.92 3.69 4.11
Total Ranking TTM # 3373 # 285 # 2614 # 426 # 2528
Seq. Current Liabilities TTM Growth -19.89 % -14.32 % -34.15 % -2.95 % 3.32 %
Seq. Cash & cash equivalent TTM Growth 23.07 % -10.17 % -12.12 % -12.98 % -12.58 %

Quick ratio ranking by company, industry and sector >> Back to GHSI Financial Strength Comparisons >> Go to Compare GHSI Quick Ratio to its Competitors

On the trailing twelve months basis GHSI Cash & cash equivalent soared by 77.18 % in Q2 2024 year on year, while Current Liabilities plummeted to $1 millions, this led to increase in in Guardion Health Sciences Inc 's Quick Ratio to 7.92, above GHSI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 468 other companies have achieved higher Quick Ratio than Guardion Health Sciences Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 285 to 3373.

Explain Quick Ratio?
How much Cash & cash equivalents GHSI´s has?
What are GHSI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 469
Healthcare Sector # 958
Within the Market # 3373


trailing twelve months Quick Ratio Statistics
High Average Low
17.45 6.93 0.58
(Mar 31 2021)   (Sep 30 2017)




Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2024 MRQ Cash & cash equivalentJun 30 2024 MRQ Current Liabilities
Moonlake Immunotherapeutics  42.32 $ 519.800  Millions$ 12.282  Millions
Rapport Therapeutics Inc   41.52 $ 336.139  Millions$ 8.095  Millions
Structure Therapeutics Inc   40.92 $ 927.119  Millions$ 22.659  Millions
Oramed Pharmaceuticals Inc  40.92 $ 152.737  Millions$ 3.733  Millions
Design Therapeutics Inc   40.82 $ 261.016  Millions$ 6.394  Millions
Third Harmonic Bio Inc   40.20 $ 255.331  Millions$ 6.352  Millions
Viking Therapeutics Inc   38.06 $ 942.263  Millions$ 24.759  Millions
Tyra Biosciences Inc   36.00 $ 373.796  Millions$ 10.382  Millions
Dianthus Therapeutics Inc   35.97 $ 360.707  Millions$ 10.029  Millions
Ars Pharmaceuticals Inc   33.32 $ 218.744  Millions$ 6.565  Millions
Ionis Pharmaceuticals Inc   31.03 $ 5,221.001  Millions$ 168.279  Millions
Sagimet Biosciences inc   29.84 $ 166.373  Millions$ 5.575  Millions
Edgewise Therapeutics inc   29.79 $ 511.751  Millions$ 17.176  Millions
Immunome Inc   29.61 $ 278.353  Millions$ 9.400  Millions
Aprea Therapeutics Inc   28.27 $ 28.695  Millions$ 1.015  Millions
Roivant Sciences Ltd   26.41 $ 5,678.514  Millions$ 215.045  Millions
Arca Biopharma Inc  26.19 $ 33.283  Millions$ 1.271  Millions
Dyne Therapeutics Inc   26.18 $ 778.838  Millions$ 29.753  Millions
Jade Biosciences Inc   25.93 $ 177.440  Millions$ 6.842  Millions
Arrivent Biopharma inc   24.69 $ 298.669  Millions$ 12.098  Millions
Disc Medicine Inc   24.66 $ 500.945  Millions$ 20.310  Millions
Akero Therapeutics Inc   24.39 $ 760.194  Millions$ 31.174  Millions
Atrium Therapeutics Inc   24.20 $ 1,300.589  Millions$ 53.750  Millions
Morphic Holding inc   23.71 $ 628.366  Millions$ 26.505  Millions
Vera Therapeutics Inc   23.58 $ 384.387  Millions$ 16.302  Millions
Liquidia Corporation  23.18 $ 133.093  Millions$ 5.741  Millions
Xenon Pharmaceuticals Inc   23.06 $ 721.535  Millions$ 31.285  Millions
Bridgebio Oncology Therapeutics Inc   22.94 $ 1.815  Millions$ 0.079  Millions
Novabridge Biosciences  22.70 $ 173.398  Millions$ 7.638  Millions
Boundless Bio Inc   22.08 $ 179.290  Millions$ 8.120  Millions

Date modified: 2026-09-12T06:22:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.